All In MedTech

Device Trial Radar · NCT07874048

CENTAURI Post-Market Clinical Registry

Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Dec 2026

Primary completion

Dec 2029

Study completion Dec 2029

Sponsor

Lead sponsor
CardioFocusNot on our public-company list
Sponsor type
Industry
First posted
Oct 14, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this post-market clinical registry is to collect realworld clinical experience across multiple European centers regarding the safety and efficacy of the CENTAURI System

Conditions

  • Paroxysmal AF

Interventions

  • CENTAURI System in conjunction with commercially available ablation cathetersDevice

    Pulsed Field Ablation using the CENTAURI System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety OutcomeTime frame: 24 months
  2. Efficacy Outcome Acute SuccessTime frame: at the end of the index ablation procedure
  3. Efficacy Outcome Chronic SuccessTime frame: 24 months

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.